Crescita Therapeutics GAAP EPS of $0.04, revenue of $5.39M
2025-11-05 13:36:13 ET
More on Crescita Therapeutics Inc.
- Seeking Alpha’s Quant Rating on Crescita Therapeutics Inc.
- Financial information for Crescita Therapeutics Inc.
Read the full article on Seeking Alpha
For further details see:
Crescita Therapeutics GAAP EPS of $0.04, revenue of $5.39MNASDAQ: CRRTF
CRRTF Trading
0.0% G/L:
$0.3332 Last:
2,500 Volume:
$0.3332 Open:



